Drastic Increase of Autism Reported

Autism spectrum disorder (ASD) has a prevalence of 1 in 68 children – a 30% increase since 2012 according to the Center for Disease Control and Prevention (CDC). ASD was once a rare disorder but is occurring more frequently than before, as more cases are being diagnosed each year. The reason for this increase may be linked to certain ingredients found in vaccines, specifically aluminum formulated vaccines. Dr. Stephanie Seneff, a funded CMSRI researcher, has reviewed empirical data that confirms autism symptoms related to aluminum and acetaminophen exposure.

Autism and ASD can be defined as a condition characterized by impaired cognitive and social skills along with compromised immune function. The fact that ASD rates have rapidly increased over the last two decades suggests that there are environmental components that lead to its prevalence. The root cause of ASD is still unknown; however, current research is suggesting that the use of vaccines are playing a role in its development. In her review titled Empirical Data Confirm Autism Symptoms Related to

Aluminum and Acetaminophen Exposure, Dr. Seneff points out the word frequency patters in the CDCs Vaccine Adverse Events Reporting System (VAERS) database.

The VAERS is a database executed by the U.S. government that allows doctors and patients to report any adverse reactions noted in association with vaccines. After conducting a search of the words “autism” and “autistic,” Dr. Seneff plotted the word frequencies based on year and could visually graph spikes in adverse reactions with vaccines and the aforementioned keyword.


“The incidence of autism-related adverse events in the VAERS database continued to rise over the time period after the amount of thimerosal in the vaccines had been sharply reduced. We hypothesize that this unanticipated consequence is due to simultaneous increases in the aluminum content, attributed to an increased number of required vaccines, intentional addition of aluminum to achieve an adjuvant effect, as well as the likely further accumulation of aluminum as a consequence of leaching, given the new practice of storage in individual glass vials with rubber stoppers. We identified several severe adverse reactions that were much more prevalent in reports from the second decade of the data, and showed that these same symptoms were also much more prevalent for reports involving aluminum-containing vaccines compared to reports on vaccines without aluminum, over the entire data set. These symptoms include seizure, cyanosis, gaze palsy, depression, fatigue, insomnia, and death.”

With the above database available from the CDC, researchers can find specific trends relating aluminum to autism by the noted adverse reactions. As autism continues to be a prevalent disorder with more cases emerging everyday, suggesting the use of aluminum in vaccines could be a part of its cause is plausible. It could be hypothesized that if aluminum is forgone in vaccines and other products, autism cases have the potential to decrease.

Who’s Guarding What?

May 2006, the Gardasil vaccine was approved for use in the United States in a bid to stop the spread of four strains of the human papillomavirus (HPV) which can lead to cervical cancer. Since then, media outlets have highly praised the vaccine and it has been marketed and promoted all over the world, whilst the vaccines adverse side effects have been pushed aside, leaving those with negative reactions to suffer.

Did you know that there are over 100 strains of the HPV virus, which is a sexually transmitted disease?  How can a vaccine be highly praised when 96% of the strains continue to pose a risk – is the vaccine worth it?

Longitudinal studies have not been completed in regards to this relatively ‘new’ vaccine and this may lead to major concerns and ramifications if it’s continued to be injected into women. For several decades, numerous case reports and studies documenting neurological and autoimmune adverse reactions following the use of various vaccinations have been conducted but not for the HPV vaccines.

Two researchers funded by the Children’s Medical Safety Research Institute, Christopher Shaw and Lucija Tomljenovic, found two young women who suffered from fatal cerebral vasculitis-type symptoms, following a vaccination with the HPV vaccine Gardasil. Cerebral vasculitis is a serious disease, typically resulting in deadly outcomes if it is left undiagnosed and untreated. In some cases vaccination may be the triggering factor of fatal autoimmune/neurological events.

Shaw and Tomljenovic discovered an interesting correlation that involved certain antibodies and antigens found in Gardasil. They discovered that these antibodies and antigens were stained in the brain tissue of two women. This link might have explained the death of these individuals because the autoimmune vasculitis may have potentially been triggered by the cross-reactive HPV-16L1 antibodies found in Gardasil.

The case study showed signs of the two women having antibodies and antigens adhered to their post-mortem brain tissue. Some of the Gardasil antibodies were binding to the wall of the cerebral blood vessels, causing the body to abnormally activate an immune response so as to attack the antibodies; however, the response triggered the immune attack towards self-tissue, resulting in a fatal outcome.

Shaw and Tomljenovic concluded that HPV vaccines containing HPV-16L1 antigens, pose an inherent risk for triggering potentially fatal autoimmune vasculopathies. The HPV vaccine Gardasil continues to be used on many young women around the world, even though its adverse effects are beginning to surface.

Could The Use Of Antiperspirants Be Linked To Breast Cancer?

Antiperspirants are used by millions, if not billions of people worldwide. They are generally used to combat body odour and prevent underarm perspiration. However, antiperspirants contain many chemicals, whether you chose to use the gel based application, the solid bar product or the widely used aerosol spray.

What many people are unaware of is the fact that some antiperspirants are aluminum-based and aluminum is a non-essential metal in the human body, since it is permeable to the skin and can easily be absorbed. This being the case, scientists have questioned whether or not there is a correlation between the constant use of aluminum-based antiperspirants and the growing number of women developing breast cancer..

Since ‘breast cancer is the most common malignancy found in women and the leading cause of death among women aged 35-54, there may be a relationship between breast cancer and aluminum. The daily application of antiperspirant could result in the presence of aluminium in underarm tissue and the surrounding areas but there has been almost no data or research on the topic until recently.

There are a few potential factors that can cause breast cancer, including genetics and environmental factors; however the root cause of the disease is still unknown.

Dr. Christopher Exley, a scientist funded by the Children’s Medical Safety Research Institute, has recently conducted a study focusing on 17 women with breast cancer from the UK. Upon studying the patient’s cancerous breast tissues, he discovered that an alarming number of the women had traces of aluminum within the tissues.

Each patient in the study underwent a mastectomy and biopsies were taken from four different regions of the breast, the outer (axilla and lateral) and the inner (middle and medial). Upon examination of the breast tissues, aluminum content was identified in each region but no significant differences were found in the concentrations of aluminum. However, there were clear trends within each of the individual’s breast tissue that indicated the distribution of aluminium, across the breast.

After collecting the data, a matched-pair analysis showed that the aluminum concentration was not evenly distributed and the aluminum found in the outer breast region was significantly higher than the inner breast region. This analysis may be linked to the daily underarm use of aluminum-based antiperspirants because a higher concentration of aluminium was discovered near the outer breast tissue.

In the study, Dr. Exley was able to confirm the presence of aluminum in the cancerous breast tissue and its possible regional distribution within the breast. “Higher content of aluminum in the outer breast tissue may be explained by this region’s closer proximity to the underarm, where the highest density of application of antiperspirant, could be assumed.”

As more studies indicate the adverse reactions to aluminum in the body, it may raise awareness to eventually end the usage of this non-essential metal.

With Ebola in the News, it’s Time to Talk Vaccine Research

The Ebola virus has been a hot topic of discussion in the news over the past couple of weeks but the virus has actually been around for quite some time. It first emerged in Africa during the mid-1970’s and is believed to be carried and transmitted by the fruit bat. Once contracted by a human, the incubation period can be anything from two days to three weeks. Symptoms include fevers, headaches, sore throats and muscle pain followed by a rash, vomiting, diarrhoea and a decreasing liver and kidney function.

Between 1976, when the Ebola virus first appeared and 2013, the World Health Organization had reported 1,716 cases. The 2014 outbreak in Africa saw numbers rise to a staggering 2,615, as the outbreak began to spread to other parts of the globe. The medical profession has found it increasingly difficult to cure the virus because as yet, there isn’t a sufficient solution that can be mass produced.

Currently, there are efforts to regress and cure Ebola and USA Today has reported that two American missionaries who contracted the virus, whilst working in West Africa, received an experimental treatment and have been released from hospital. Doctors treating the missionaries reported that their former patients are no longer contagious and do not pose a threat to others. However, the treatment that the two individuals received upon their stay in hospital is questionable.

The missionaries were administered with the experimental vaccine ZMapp, even though human testing was never completed and ZMapp was still being tested on animals. No human clinical trials have so far been conducted and the side effects of the vaccine are yet to be discovered because of the lack of research. This raises concerns because the treatment could potentially only act as a ‘band-aid’ to a serious threat. The World Health Organization has announced that the treatment was based upon the ‘particular circumstances’ surrounding the Ebola virus outbreak and mentioned that the efficacy and adverse effects of the vaccine are unknown

The drug manufacturer of ZMapp claims that there is no longer any more of the vaccine left and doctors have yet to see proof of whether ZMapp had been successful, even though the patients showed no signs of the Ebola virus in their bodies. Although the two Americans have been released from the hospital, it is said that the Ebola virus can have an incubation period of up to 21 days. In the event that more ZMapp is produced and sent for more clinical trials, the long-term side effects will remain unknown due to lack of research.

Our goal at CMSRI is to raise awareness of the toxins and adverse effects vaccines pose to the human body. This new, experimental vaccine should be placed under the same scrutiny because the long-term effects have yet to be discovered or studied.